Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
gobears1985's Profile
Displaying 101-150 of 305 result(s).
AMBS Amarantus Bioscience Holdings
04/23/2018 4:48:28 PM
The company name is different too â (1)
AMBS Amarantus Bioscience Holdings
04/03/2018 10:18:15 PM
“all of them are able to attract (5)
AMBS Amarantus Bioscience Holdings
03/29/2018 4:40:10 PM
Another big T today. 308,300. Thatâ
AMBS Amarantus Bioscience Holdings
03/17/2018 6:48:30 PM
Stop changing the subject. Explain (6)
AMBS Amarantus Bioscience Holdings
01/03/2018 2:10:46 PM
I’m still here too. (1)
AMBS Amarantus Bioscience Holdings
12/22/2017 11:02:12 AM
We were over .20 briefly earlier th (2)
AMBS Amarantus Bioscience Holdings
12/21/2017 5:36:33 PM
That’s what ESS is for. We’ll b (4)
AMBS Amarantus Bioscience Holdings
07/19/2017 9:41:51 AM
50,000 at 29 cent avg
AMBS Amarantus Bioscience Holdings
06/02/2017 4:26:31 PM
Looks like we got ourselves a bashe (7)
AMBS Amarantus Bioscience Holdings
08/24/2016 11:40:41 PM
According to the last filing, they (2)
AMBS Amarantus Bioscience Holdings
08/04/2016 7:49:35 PM
...or it could be tomorrow for all (3)
AMBS Amarantus Bioscience Holdings
07/13/2016 5:18:31 PM
This is for getin-shacked since he (8)
AMBS Amarantus Bioscience Holdings
07/12/2016 11:22:39 PM
There's not really a question in th (9)
AMBS Amarantus Bioscience Holdings
07/10/2016 8:50:45 PM
Giant Congenital Hairy Nevus has no (4)
AMBS Amarantus Bioscience Holdings
07/01/2016 1:06:22 PM
Sorry but what's happening on Twitt (6)
AMBS Amarantus Bioscience Holdings
04/21/2016 6:13:34 PM
I understand that concept and it is (3)
AMBS Amarantus Bioscience Holdings
04/19/2016 6:11:51 PM
I don't believe that comment was ev (2)
AMBS Amarantus Bioscience Holdings
04/15/2016 12:29:08 PM
Your sentiment appears different on (1)
AMBS Amarantus Bioscience Holdings
03/18/2016 7:28:05 PM
I'm not convinced Lympro is a dud a (1)
AMBS Amarantus Bioscience Holdings
03/18/2016 6:42:55 PM
Now they will have a lot more tests (10)
AMBS Amarantus Bioscience Holdings
03/07/2016 7:01:42 PM
I was thinking he was JP but he spe (9)
AMBS Amarantus Bioscience Holdings
01/29/2016 3:28:29 PM
Looks like he may be the president
AMBS Amarantus Bioscience Holdings
01/29/2016 12:40:59 PM
Dustin Johns is DocStock from ihub
AMBS Amarantus Bioscience Holdings
01/27/2016 2:42:40 PM
GC is not going to step down, so th
AMBS Amarantus Bioscience Holdings
01/06/2016 5:15:20 PM
I stand corrected. Thanks for posti
AMBS Amarantus Bioscience Holdings
01/06/2016 4:57:24 PM
He not only retweeted it, but he al
AMBS Amarantus Bioscience Holdings
01/06/2016 4:54:49 PM
I don't believe the 8th was ever me
AMBS Amarantus Bioscience Holdings
12/16/2015 11:56:36 AM
I'm betting not. You're still inves
AMBS Amarantus Bioscience Holdings
12/15/2015 10:59:52 PM
I'm not saying it would be announce
AMBS Amarantus Bioscience Holdings
12/15/2015 5:19:11 PM
Your understanding differs from min
AMBS Amarantus Bioscience Holdings
12/10/2015 11:54:38 AM
I'm pretty sure it's just a fancy w
AMBS Amarantus Bioscience Holdings
12/09/2015 10:53:58 AM
Was there an expectation of news co
AMBS Amarantus Bioscience Holdings
11/24/2015 2:26:31 PM
The key part of that arrangement wi
AMBS Amarantus Bioscience Holdings
11/06/2015 5:11:49 PM
The bottom line with all of our bac
AMBS Amarantus Bioscience Holdings
11/06/2015 2:10:37 PM
It certainly could. I have no probl
AMBS Amarantus Bioscience Holdings
11/06/2015 1:46:16 PM
1) "counseled by several industry v
AMBS Amarantus Bioscience Holdings
10/27/2015 7:32:28 PM
Your post came first, so he plagiar
AMBS Amarantus Bioscience Holdings
10/27/2015 4:59:31 PM
I cant imagine being so careless a
AMBS Amarantus Bioscience Holdings
04/10/2015 1:55:27 PM
When you don't like the message....
AMBS Amarantus Bioscience Holdings
03/17/2015 9:57:14 PM
First of all, way to miss the point
AMBS Amarantus Bioscience Holdings
03/17/2015 5:35:18 PM
Is this a new thought or the same t
AMBS Amarantus Bioscience Holdings
03/17/2015 10:04:32 AM
Without going back and checking, I
AMBS Amarantus Bioscience Holdings
03/13/2015 12:17:26 AM
All of this coming from a guy whose
AMBS Amarantus Bioscience Holdings
03/12/2015 3:16:59 PM
Hey biotechexpert -- I know you can
AMBS Amarantus Bioscience Holdings
03/11/2015 9:31:21 PM
Mouth breathers.
AMBS Amarantus Bioscience Holdings
03/11/2015 9:36:07 AM
I don't really care about estimates
AMBS Amarantus Bioscience Holdings
03/11/2015 8:50:11 AM
We must have been typing the same m
AMBS Amarantus Bioscience Holdings
03/11/2015 8:49:20 AM
How exactly do you know that Lympro
AMBS Amarantus Bioscience Holdings
03/10/2015 10:43:20 PM
Seems that many here need an experi
AMBS Amarantus Bioscience Holdings
03/10/2015 3:40:31 PM
You'd just find new reasons to comp
Go to page:
  • << First
  • < Previous
  • 2
  • 3
  • Next >

Recent Articles

  • SoftBank's Strategic $22.5 Billion Deal with OpenAI Unfolds
  • MSI Empowering Esports Through Innovative Gaming Solutions
  • Investors of Tronox Holdings Face Crucial Class Action Decisions
  • Urgent Investment Action Required for MoonLake Immunotherapeutics
  • Opportunities for Investors in Quantum Corporation Securities Case
  • Unpacking Major Events in Trump's 40th Week of Leadership
  • BayCare Cancer Institute Unveils Proton Therapy Breakthrough
  • XiuShan Mining Enhances Cloud Services for Bitcoin Mining Access
  • Exploring Innovative Income Models in Digital Asset Mining
  • Lantheus Holdings, Inc. Investors Can Pursue Securities Case
  • Visionary Holdings Faces Nasdaq Compliance Challenges Ahead
  • Trump's Steady Approval Amid Shutdown and Controversial Renovations
  • The Influence of the Best Beaches in Los Angeles on Local Property Prices
  • The Power of Female Consumers in Today’s Economy
  • Visionary Holdings Inc. Addresses Nasdaq Compliance Notification
  • Keystone Resort Kicks Off Winter Season with Exciting Events
  • How to Spot a Tech Startup That Is Investment-Ready
  • Agadir’s Tourism Upswing: Clear Signals for Investors
  • Hormel Foods Initiates Safety Recall for Fire Braised Products
  • How to Market Your Pennsylvania Rental Property to Couples and Young Professionals
  • SpaceX Creates Ripples in Crypto Market with Massive Bitcoin Move
  • How Financial Institutions Are Building Resilience Into Their Lending Portfolios
  • Changpeng Zhao's Vision on Crypto's Contribution to Economy
  • The ROI of Contractor Education: Is It Worth Paying for Licensing Prep?
  • Why Social Media Engagement Metrics Are Quietly Becoming a Financial Valuation Signal for Modern Brands
  • RakeBit Shines as a Preferred Choice in No KYC Casinos
  • Elevate Your Game with BitStarz: The Top Choice for Plinko Players
  • BitStarz: Your Ultimate Guide to No Deposit Casino Bonuses
  • Understanding Your Rights with Zions Bancorporation after Losses
  • Discover the Revolutionary Cyber Heater for Optimal Home Comfort
  • Essential Travel Insurance Insights for Indian Tourists Abroad
  • How Small Business Owners Can Achieve Financial Agility in Uncertain Times
  • Exploring the Best Online Casinos for Fast Payouts in 2025
  • Trump's Diplomatic Approach: Meeting Kim Jong Un Again?
  • Kamala Harris Looks Ahead: Potential 2028 Presidential Bid
  • Turning Condo Ownership Into a Profitable Long-Term Investment
  • How to Find the Perfect New Home in Your Desired Location
  • Discover RubyReels: Australia’s Next Top Online Casino in 2025
  • DeLeion Capital Seizes Opportunities in Crypto Landscape
  • EU Takes Bold Steps to Secure Rare Earth Supply Chain
  • What Investors Need to Know About Jasper Therapeutics Class Action
  • KBR Investors Urged to Act Ahead of Class Action Deadline
  • Trump's Rally in New Jersey: A Clash of Political Titans
  • Discover the Excellence of Kratom Bird's Online Shopping Experience
  • Avacta Unveils Promising Dual Payload Data from Cancer Therapies
  • Exploring the Breakthrough Potential of BBO-10203 in Cancer Treatment
  • AlphaTON Capital and Cyncado Therapeutics Advance Cancer Research
  • Investor Insights: Key Stocks Sparking Discussions This Week
  • Novartis Unveils Promising Results in Autoimmune Research
  • Innovative CLN-978 Shows Promise for Autoimmune Treatments
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site